Outcome of Patients with Single Ventricles who Initially did not Indicate Fontan Completion After Stage II Palliation
Pediatric Cardiology · 13.07.2026
DOI: 10.1007/s00246-026-04382-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, online erschienen am 13.07.2026. Verfasst von Carolin Niedermaier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Herzzentrum München.
Abstract (Originalsprache)
Despite an early-staged Fontan completion strategy, certain patients after bidirectional cavopulmonary shunt (BCPS) could not undergo swift Fontan completion. This study aimed to clarify the clinical course of these patients. Among all infants with univentricular hearts who underwent BCPS between 1998 and 2022, those who could not undergo the Fontan completion at the initial assessment were identified. The reasons, clinical course, and delayed Fontan completion of these patients were evaluated. A total of 491 patients underwent cardiac catheterization for evaluation of Fontan completion at a median age of 1.8 (1.6–2.3) years and 1.4 (1.2–1.9) years after BCPS. Among them, 470 patients underwent subsequent Fontan (Group F), and 21 patients did not (Group C). There were various reasons, including left pulmonary artery stenosis in 14 patients, high pulmonary artery pressure (PAP) in 7, significant atrioventricular valve regurgitation in 6, and systemic ventricular dysfunction in 5. Delayed Fontan completion was performed in 16 patients at a median age of 5.5 (3.7–5.9) years. Survival at 5 years was 90.9% in Group C and 97.2% in Group F ( p = .005). A need for additional pulmonary blood flow (APBF) after BCPS ( p = .015) and higher PAP at initial assessment ( p = .003) were risk factors for delaying Fontan completion. Left pulmonary artery stenosis requiring APBF and high PAP were contraindications to early Fontan completion. Delayed Fontan completion was possible in most patients with acceptable outcomes, suggesting improvement of Fontan candidacy during follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
- Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany.
- Europäisches Kinderherzzentrum München, Munich, Germany.
- Department of Pediatric Cardiology and Congenital Heart Disease, TUM University Hospital, German Heart Center, Munich, Germany.
- Department of Cardiovascular Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
- Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany. ono@dhm.mhn.de.
Förderung
- Deutsches Herzzentrum München
Zitieren
APA
Niedermaier, C., Przybilla, C., Schaeffer, T., Matsubara, M., Ruda, C., Palm, J., Piber, N., Ewert, P., Hörer, J., & Ono, M. (2026). Outcome of Patients with Single Ventricles who Initially did not Indicate Fontan Completion After Stage II Palliation. Pediatric Cardiology. https://doi.org/10.1007/s00246-026-04382-1
Vancouver
Niedermaier C, Przybilla C, Schaeffer T, Matsubara M, Ruda C, Palm J, et al. Outcome of Patients with Single Ventricles who Initially did not Indicate Fontan Completion After Stage II Palliation. Pediatric Cardiology. 2026. doi:10.1007/s00246-026-04382-1
BibTeX
@article{Niedermaier2026,
author = {Niedermaier, Carolin and Przybilla, Cornelius and Schaeffer, Thibault and Matsubara, Muneaki and Ruda, Christina and Palm, Jonas and Piber, Nicole and Ewert, Peter and Hörer, Jürgen and Ono, Masamichi},
title = {Outcome of Patients with Single Ventricles who Initially did not Indicate Fontan Completion After Stage II Palliation},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-026-04382-1}
}
EUVIMED